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 ABBREVIATIONS 
 
CCA, convex constraint analysis; EIAV, equine infectious anemia virus; FIV, 
feline immunodeficiency virus; FIV-rp24, recombinant FIV p24 protein; HIV, human 
immunodeficiency virus; NTA, nitrilotriacetic acid; SIV, simian immunodeficiency 
virus; W40F, recombinant p24 protein with Phe at position 40 instead of Trp; W126F, 
recombinant p24 protein with Phe at position 126 instead of Trp; W40/126F, 
recombinant p24 protein with Phe at positions 40 and 126 instead of Trp. 
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SUMMARY 
 
The gene coding for the major capsid protein of feline immunodeficiency virus 
(FIV) has been cloned into the expression vector pQE60 which allows protein 
purification by affinity chromatography on a Ni-Nitrilotriacetic-Agarose column. The 
gene was expressed in Escherichia coli and the resultant soluble protein (FIV-rp24) 
purified to electrophoretic homogeneity. The amino acid composition of the 
recombinant protein is practically coincident with that predicted from the DNA 
sequence. This protein has two tryptophan residues at positions 40 and 126 that 
have been replaced by phenylalanine  by site directed mutagenesis to obtain two 
single mutants and a double mutant. Circular dichroism and fluorescence 
spectroscopy were employed to study the structural features of FIV-rp24 protein and 
its tryptophan mutants. The analysis of the CD spectra indicated that α-helix is the 
major secondary structure element (48-52%) and that the overall three-dimensional 
structure is not modified by the mutations. The fluorescence emission spectra pointed 
out that both Trp residues occupy a highly hydrophobic environment. Moreover, the 
different Tyr fluorescence intensities of wild type and mutant proteins are indicative of 
the existence of resonance energy transfer processes to nearby Trp. The individual 
contributions of each tryptophan residue to the spectroscopic properties of the  wild 
type protein were obtained from the spectra of all these proteins. Thermal 
denaturation studies indicate that both tryptophan residues do not contribute equally 
to the stabilization of the three-dimensional structure. 
 
Keywords: FIV core protein; tryptophan mutants; site-directed mutagenesis; circular 
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dichroism; fluorescence spectroscopy. 
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INTRODUCTION 
 
Lentiviruses are a subfamily of retroviruses to which belong, among others, 
feline immunodeficiency virus (FIV), equine infectious anemia virus (EIAV), simian 
immunodeficiency virus (SIV) and human immunodeficiency virus (HIV), the 
etiological agent of acquired immunodeficiency syndrome. The biological and genetic 
relationships between the non-human lentiviruses and HIV-1 render them potentially 
useful models for understanding the pathogenesis of HIV-1, and for evaluating 
methods of effective treatment and control of viral infection [1]. 
FIV, a common pathogen in both domestic and wild cats worldwide, was first 
isolated in 1986 from specific pathogen-free kittens inoculated with peripheral blood 
or plasma from a cat with an acquired immunodeficiency syndrome-like disease in 
the United States [2, 3]. FIV was then classified as a lentivirus on the basis of virion 
morphology, Mg2+-dependent reverse transcriptase activity, and the propensity for 
persistent infection in cats [2, 3]. This lentivirus causes generalized 
lymphoadenopathy and increased susceptibility to opportunistic infections, eventually 
culminating in death [4]. 
Members of the lentiviruses share many common features, including a large 
RNA genome of 9 kb or more in length, and exhibit conserved genomic organization 
[5]. The Gag (or core) open reading frame is located at the 5' end of the genome, 
immediately following the 5' long terminal repeat, and is the first gene to be translated 
[5]. Consistent with other lentiviruses, proteolytic processing sites  within the Gag 
polyproteins of  FIV were identified [6]. The precursor protein of Gag is processed to 
yield different proteins: p15 (matrix protein), p24 (capsid protein), p7 (nucleocapsid 
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protein) and p6 [6, 7]. 
An alignment of lentiviral gag amino acid sequences indicates that the region 
of  highest identity includes the major core protein and the nucleocapsid protein. 
Pairwise comparisons of  FIV to other lentiviruses reveal important amino acid 
identities with EIAV (49%), visna virus (43%), and HIV-1 (40%) [8, 9]. Indeed, 
serological cross-reactivity to the capsid protein was demonstrated among FIV, visna 
virus and EIAV [10, 11]. This is indicative of the presence of conserved interspecies 
determinants among the lentiviral core proteins, prompting suggestion that the major 
core proteins of at least HIV-1, FIV, and EIAV are organized into similar antigenic 
domains. 
Moreover, the high degree of amino acid similarity combined with 
immunological cross-reactivities and conserved function, suggest that the 
three-dimensional structure of the lentiviral core proteins are likely to be related. In 
fact, the core proteins of EIAV and HIV have been shown to possess the same 
overall three-dimensional structure being organized into two domains linked by a 
flexible extended peptide [12-16]. The N-terminal domain has a compact bullet shape 
composed of five coiled-coil α-helices, with two additional short α-helices following an 
extended proline-rich loop [12, 13]. The C-terminal domain has four bundled 
α-helices and an extended strand [14]. The EIAV protein crystallizes as  dimers with 
head-to-head interactions [15] while the dimers observed in crystals of HIV capsid 
protein complexed with a monoclonal antibody Fab have head-to-tail interactions 
[16]. 
 In this study we report the cloning, expression and purification of the major 
core protein of FIV. The recombinant protein has two tryptophan residues at positions 
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40 and 126, which have been replaced by one or two phenylalanine residues to 
obtain two single mutants and one double mutant. The CD and fluorescence 
properties of the wild type and mutant proteins have been determined. From them, 
the individual contribution of the aromatic side chains have been resolved. 
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EXPERIMENTAL PROCEDURES 
 
Materials 
 
Restriction enzymes, polymerases and other molecular biology reagents were 
obtained from New England Biolabs and Qiagen. CL-6B Ni-NTA agarose  was 
purchased from Qiagen. All other reagents were from Merck. 
 
Cloning strategy 
 
The gene that codes for the major core protein of FIV was amplified by a 
standard PCR reaction using Vent polymerase (New England Biolabs). The following 
conditions were employed: 5 cycles at 94 C, 42 C and 72 C, each for 1 min; 
followed by 25 cycles at 94 C, 55 C and 72 C, each for 1 min. A final ‘filling-in’ step 
at 72 C for 5 min was incorporated to assure that the ends of the PCR reaction were 
‘flush’. The product of the PCR reaction was run on an agarose gel (0.8%), and a 699 
bp product was extracted using the ‘Qiaex’ DNA extraction kit (Qiagen). The primers 
used for the PCR were: 
p24-NcoI(+): GCCCATGGTACCTATTCAAACAGTA 
p24-BglII(-): GGAGATCTAAGAGCTTCTGCCAAGAG 
They were designed in such a way  that the product had an NcoI restriction 
site (CCATGG) at its 5' end and a BglII restriction site (AGATCT) at its 3' end. The 
699 bp DNA fragment  was doubly digested  by the restriction enzymes NcoI and 
BglII and cloned into the expression vector pQE60 (Qiagen) which had been cleaved 
 
 
9
with the same two enzymes to obtain the plasmid pQE60-FIV/p24. pQE60 is an 
expression vector that adds a six histidines sequence at the carboxyl-terminal end of 
the protein. The initiator Met residue is coded by the triplet ATG within the NcoI 
restriction site. The ligation was carried out by incubating 50 ng of both plasmid and 
insert and 200 units of T4-DNA-ligase (New England Biolabs) in a total volume of 20 
μl for 15 h at 16 C. A positive clone was identified by restriction analysis of mini-prep 
DNA and ultimately by automated sequencing which was performed by the 
Universidad Complutense DNA sequencing Facility by using an ABI Prism 377 
system. 
 
Preparation of tryptophan mutants of FIV major core protein 
 
The tryptophan mutants were obtained using the PCR technique and the 
plasmid pQE60-FIV/p24 as template. The primers used to generate the mutations 
were: 
W40F(+): CAATTGTTCTTTACTGCCTTCTCTGCA 
W40F(-): GGTGAGGAAGTTCAATTGTGGTTT 
W126F(+): TGGTATCTAGAGGCATTAGGA 
W126F(-): AGGATGCAGTGTAGAGCATTTTATCTAGAG 
These primers have specific changes of bases corresponding to the mutation 
and they incorporate new restriction sites, MfeI (CAATTG) in the W40F mutant, and 
XbaI (TCTAGA) in the W126F mutant. The PCR reactions were carried out 
employing the following conditions: 5 cycles at 94 C (30 s), 37 C (12 s), 72 C (20 
s); followed by 30 cycles at 94 C (30 s), 55 C (12 s), 72 C (20 s) and a final step at 
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72 C (7 min). For each mutant two PCR reactions were carried out. Thus, for W40F 
mutant p24-NcoI(+)/W40F(-) and W40F(+)/p24-BglII(-) primer pairs were used. The 
two fragments obtained were digested with the restriction enzymes, MfeI (W40F) or 
XbaI (W126F), and ligated. The DNA fragments that encoded the W40F and W126F 
mutants, generated by ligation, were amplified by a second PCR reaction, digested 
with the restriction enzymes NcoI and BglII and cloned into the expression vector 
pQE60 cleaved with the same restriction enzymes to obtain the plasmids 
pQE60-W40F and pQE60-W126F. The following strategy was employed to obtain the 
double mutant: pQE60-W40F plasmid was digested with the restriction enzymes NcoI 
and HindIII to get a 216 bp fragment, and pQE60-W126F plasmid was digested with 
HindIII and BglII to get a 473 bp fragment. These fragments were ligated to the 
pQE60-FIV/p24 plasmid digested with the restriction enzymes NcoI and BglII. The 
changes introduced were confirmed by digestion of the pQE60-W40F and 
pQE60-W126F plasmids with the restriction enzymes MfeI or XbaI respectively, and 
by automated DNA sequencing. 
 
Expression and purification of FIV core protein and tryptophan mutants 
 
E. coli  strain M15[pREP4] was transformed with pQE60-FIV/p24 plasmid by 
the CaCl2 method [17] and plated onto a LB (Luria-Bertani) plate supplemented with 
100 μg/ml ampicillin and 25 μg/ml kanamycin. These cells have multiple copies of the 
pREP4 plasmid, which has the lacI gene [18], that encodes the lac repressor and 
gives kanamycin resistance to the cell. A single colony was selected and used to 
inoculate 100 ml of LB media supplemented with 100 μg/ml ampicillin and 25 μg/ml 
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kanamycin. This culture was grown overnight at 37 C and then used to inoculate 2 L 
of the same media which were grown until A600 reached a value of 0.5-0.6. The 
expression of the protein was induced by 0.25 mM IPTG for 4 h at 37 C. The cells 
were harvested by centrifugation at 6000 rpm for 10 min. Cell pellets were 
resuspended in 10 mM Tris, pH 8.0 (30 ml/L of cell culture) and lysed by sonication. 
The cell lysate was clarified by centrifugation at 89500 g for 30 min in a Beckman 
SW28 rotor. The supernatant was supplemented with 10 mM Imidazole and loaded 
onto a Sepharose CL-6B Ni-NTA column which had previously been equilibrated with 
10 mM Tris, 10 mM Imidazole, pH 8.0. Once the protein solution had entered the 
column, it was washed with 5 column volumes of 10 mM Tris, 10 mM Imidazole, pH 
8.0 and later with 10 mM Tris, 30 mM Imidazole, pH 8.0. The recombinant FIV-p24 
protein (FIV-rp24)  was eluted with 10 mM Tris, 200 mM Imidazole, pH 8.0. The 
presence of FIV-rp24 was monitored by SDS-PAGE throughout the purification. The 
same protocol was used to purify the mutant proteins.  
 
SDS-PAGE 
 
 Analytical polyacrylamide gel electrophoresis was performed according to the 
method  of O’Farrell [19]. 4% acrylamide stacking gel and 15% acrylamide resolving 
gel were employed. Gels were stained with Coomassie brilliant blue R-250. 
 
Amino acid analysis 
 
Approximately, 20 μg of purified protein were hydrolyzed with 5.9 N 
 
 
12
hydrochloric acid, 0.1% (w/v) phenol, at 115 C for 24 h. The amino acid analysis 
was performed on a Beckman 6300 automatic analyzer. 
 
Circular dichroism measurements 
 
Circular dichroism spectra were obtained on a Jasco J-715 spectropolarimeter 
using 0.1 cm or 1 cm pathlength cuvettes at 25 C. The protein concentration was 
0.1-0.2 mg/ml for far-UV and 1 mg/ml for near-UV. The buffer used was 10 mM 
sodium phosphate, pH 7.0. A minimum of four spectra were accumulated for each 
sample and the contribution of the buffer was always subtracted. The resultant 
spectra were smoothed using J715 Noise Reduction software. The values of mean 
residue molar ellipticity [Θ]MRW were calculated on the basis of 113 as the average 
molecular mass per residue and they are reported in terms of degree  cm2  dmol-1. 
The secondary structure of the protein was evaluated by computer fit of the dichroism 
spectra according to the algorithm Convex Constrain Analysis (CCA) [20]. This 
method relies on an algorithm that calculates the contribution of the secondary 
structure elements that give rise to the original spectral curve without referring to 
spectra from model systems. Thermal denaturation curves were obtained by 
measuring continuously the ellipticity at 208 nm over the range 25-75 C. The 
temperature in the cuvette was regulated with a Neslab RT-11 circulating water bath 
and was increased at 30 C/h. The Tm values were determined from the first 
derivative of the smoothed denaturation curves. 
 
Fluorescence measurements 
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Fluorescence studies were carried out on a SLM Aminco 8000C spectrofluorimeter, 
fitted with a 450 W xenon arc. The protein concentration was 0.05-0.1 mg/ml. A 0.4x1 
cm cuvette was used. The buffer used was 10 mM sodium phosphate, pH 7.0. The 
temperature in the cuvette (25 C) was maintained by a Polystat Hubber circulating 
water bath. Excitation was performed at 275 or 295 nm, and the emission spectra 
were recorded over the range 285-450 nm. The contribution of the buffer was always 
subtracted. The tyrosine contribution to the emission spectra was calculated by 
subtracting  from the emission spectra measured at λexc= 275 nm the emission 
spectra measured at λexc= 295 nm multiplied by a factor. The factor was obtained 
from the ratio between the fluorescence intensities measured with λexc= 275 and λexc= 
295 nm at wavelengths higher than 380 nm, where there is no tyrosine contribution. 
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RESULTS 
 
Cloning, expression and purification of FIV-rp24 and tryptophan mutants 
 
Following the strategy described in the Experimental Procedures section (Fig. 
1), the gene coding for the major core protein of FIV was cloned in the expression 
vector pQE60. The DNA sequence of the PCR-generated p24 clone was identical to 
the published sequence of the proviral DNA [9], except in the zones corresponding to 
the amino- and carboxyl-ends of the protein which, as explained below, have some 
extra amino acids. Using the plasmid pQE60-FIV/p24 as template and the 
corresponding primers, the W40F, W126F and W40/126F mutant genes were 
obtained. Their sequence was confirmed by automated sequencing and was identical 
to that of cloned p24 except where the triplet TGG has been changed to TTC (W40F) 
or TTT(W126F).  Expression of either constructed gene yielded a protein with a 
molecular mass of 27.5 kDa. Fig. 2 shows an SDS-polyacrylamide gel of the 
purification steps of FIV-rp24. Similar results were obtained for the single and double 
mutants. The protein expressed in a soluble form was subsequently purified using 
affinity chromatography on a Ni-NTA-Agarose column. The protein that eluted with 
200 mM imidazole was determined to be >95% pure by densitometry of stained SDS 
gels (Fig. 2, lane 5). Following this procedure, approximately 5 mg of FIV-rp24 
protein, 4 mg of W40F mutant, 2 mg of W126F mutant and 2 mg of the double 
mutant were obtained from 1 L of culture media.  
The amino acid sequence of the wild type recombinant protein, as deduced 
from the cDNA sequence, differs from the actual core protein, which is 223 amino 
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acids long, in the following aspects: the two additional amino acids, Met and Val, at 
the amino-terminus due to the introduction of the NcoI restriction site; an extension of 
four amino acids (Ala-Glu-Ala-Leu) at the carboxyl-terminus which in the precursor 
polyprotein are between p24 and p7 [6]; the two amino acids, Arg and Ser, at the 
carboxyl-terminus due to cloning into BglII pQE60 site; finally, the six histidine 
residues tag. Thus, the recombinant protein is 237 amino acids long and the two Trp 
occupy positions 40 and 126 which in the original protein correspond to positions 38 
and 124, respectively. The amino acid composition of FIV-rp24 and mutant proteins 
are shown in Table 1. As it can be observed, the amino acid composition of the 
cloned protein is practically coincident with that predicted from the DNA sequence. 
The lower Met content of cloned proteins could be due to either the proteolytic 
cleavage of the initiator formyl-methionine residue, as frequently reported when 
proteins are expressed and purified from E. coli [22], or the amino acid analysis 
procedure used. The number of Trp residues decreased for the mutants and, 
accordingly, the number of Phe residues increased. 
 
Absorption spectra of FIV-rp24 and tryptophan mutants 
 
When analyzed by ultraviolet spectroscopy, purified FIV-rp24 protein gave an 
absorption spectrum characteristic of a soluble protein (Fig. 3). It exhibited a 
maximum at 277 nm and two shoulders at 281 and 292 nm. The shoulder at 292 nm 
was less evident in the single Trp mutants and almost disappeared in the double 
mutant. The spectrum of the double mutant was coincident with that of free tyrosine 
in solution although it is red-shifted, indicating that protein tyrosine residues occupy a 
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 hydrophobic environment. The shoulders between 255-265 nm should be the 
contribution of the seven Phe residues. The molar extinction coefficients were 
determined by amino acid analysis of aliquots of protein solutions of known A280 and 
were 23120, 17110, 17365 and 11565 M-1 cm-1 for FIV-rp24, W40F, W126F and 
W40/126F, respectively. Therefore, a 1 mg/ml solution of these proteins was found to 
have an A280 of 0.88, 0.65, 0.67 and 0.44 respectively. 
 
Circular dichroism spectra 
 
The far-UV CD spectra of FIV-rp24 and its Trp mutants are depicted in Fig. 
4A. All the spectra show two minima at 208 and 222 nm and a maximum at 191 nm 
indicatives of a high content of α-helical structure. The assignment of the secondary 
structure elements calculated from these spectra, according to the algorithm CCA 
[20] is shown in Table 2. The major component in all the proteins is α-helix (48-52%) 
with no β-sheet present. 
The near-UV CD spectrum of FIV-rp24 is a complex mixture of multiple Cotton 
effects (Fig. 4B). A major negative band at 269 nm together with minor negative 
bands at 262, 275, 284 and 296 nm and minor positive bands at 258 and 290 nm 
were observed. The assignment of a particular band to a given residue could be 
performed by analyzing the spectra of the mutant proteins. Since the contributions of 
the inserted Phe residues to the near-UV CD spectrum above 260 nm is almost 
negligible [23], the contribution of each Trp can be obtained by difference spectra. 
Fig. 5 shows the individual contribution of Trp40 and Trp126 as determined either 
from the spectrum of wild type FIV-rp24 (FIV-rp24 - Trp mutant) or from the single 
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mutant spectra (Trp mutant - double mutant). Above 265 nm the results of both 
calculations are virtually indistinguishable. The spectrum of either Trp residue is a 
complex combination of bands. The contribution of Trp40 is positive in the entire 
wavelength range with maxima at 273, 283 and 290 nm and it should be responsible 
for the positive band observed at 290 nm in the wild type FIV-rp24. The Trp126 
spectrum has two major negative bands centered at 272 nm and 295 nm. The former 
cancels the positive contribution of Trp40 at that wavelength and the later should be 
responsible for the negative band which in native FIV-rp24 appeared at 295 nm. The 
position of the different bands indicated a more hydrophobic environment of Trp126. 
On the other hand, the spectrum of the double mutant revealed the important 
contribution of aromatic side chains other than Trp, mainly Tyr residues, to the 
near-UV CD spectrum of FIV-rp24 with negative bands at 262, 269, 278 and 284 nm. 
Addition of this spectrum to those calculated for Trp40 and Trp126 rendered the 
spectra depicted in Fig. 6. Except for the 250-265 nm range the composite spectrum 
possesses all features of the FIV-rp24 near-UV spectrum, independently of the 
method used to calculate the individual Trp contribution. 
 
Fluorescence emission spectra 
 
The fluorescence emission  spectra of FIV-rp24 and its Trp mutants are 
depicted in Fig. 7. Upon excitation at 275 nm both FIV-rp24 and W40F mutant 
exhibited a maximum at 320 nm (Fig. 7A and B) which indicates that the fluorescence 
of these proteins is highly dominated by Trp residues and that they occupy a highly 
hydrophobic environment. However, the maximum of W126F appeared at 303 nm 
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(Fig. 7C), indicative of a high contribution of Tyr residues to the fluorescence 
intensity. Moreover, the two Trp should not contribute equally to the fluorescence of 
FIV-rp24 since at 320 nm the fluorescence intensity of W40F and W126F mutants 
was respectively 70% and 50% that of wild type FIV-rp24. The spectrum of 
W40/126F mutant provided the contribution of the seven Tyr residues to the protein 
fluorescence (Fig. 7D). 
Upon excitation at 295 nm the position of the fluorescence emission maximum 
was around 321-322 nm for both wild type and single mutants but differences in 
fluorescence intensity were observed (Fig. 7). Thus, the value for W40F mutant was 
68% that of the wild type while the value for W126F mutant was only 33%. Then, the 
contribution of Trp126 to the spectrum must be twice that of Trp40. Moreover, the 
protein fluorescence of FIV-rp24 observed upon excitation at 295 nm arises almost 
exclusively from tryptophan residues as indicated by the low spectrum of the double 
mutant (Fig. 7D), which accounts for only 7% of the fluorescence intensity of the wild 
type protein. 
The difference between the fluorescence spectra obtained upon excitation at 
275 and 295 nm, being the later normalized, provides the contribution of Tyr residues 
to the protein fluorescence. In the case of wild type and W40F proteins Tyr accounts 
for almost 40% of the intensity obtained upon excitation at 275 nm and this value 
increased to 75% for W126F protein. However, in none of them the intensity was 
even close to the authentic Tyr fluorescence given by W40/126F mutant.   
 
Thermal stability of FIV-rp24 and Trp mutants 
 
 
 
19
The thermal denaturation of either protein was followed by measuring 
continuously the ellipticity  at 208 nm upon increasing the temperature at 30 C/h 
(Fig. 8). In all cases the process was cooperative and differences on the temperature 
at the midpoint (Tm) were observed. Thus, wild type protein and W40F mutant had a 
close Tm value, 63.4 ± 0.9 C and 61.2 ± 0.4 C, respectively. The stability of the 
protein decreased when Trp126 was mutated since the Tm  for W126F and double 
mutant was 52.3 ± 0.4 C and 54.4 ± 0.4 C, respectively. 
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DISCUSSION 
 
Site directed mutagenesis performed on aromatic amino acids, especially 
tryptophans, has often been used to create proteins with intrinsic probes which can 
be used to monitor their unfolding, refolding, and stability [24-26]. This procedure is 
based on the knowledge that the spectral properties of these amino acids are highly 
dependent on their three-dimensional environment. On the other hand, feline 
immunodeficiency virus represents a valuable animal model for studying the human 
immunodeficiency virus [27]. As stated before the high degree of sequence homology 
exhibited by lentiviral core proteins [8, 9] together with immunological 
cross-reactivities [10, 11] would suggest a common tertiary structure. Studies of the 
structure and folding of this family of proteins, which have important roles in virus 
morphology and assembly process [28-30], may have applications in anti-viral 
therapy and vaccine development [31, 32]. In this report we detail the cloning, 
expression and spectroscopic properties of the major core protein of FIV, as well as 
its two single tryptophan mutants (W40F and W126F) and the double mutant 
(W40/126F). 
The higher order structure of FIV-rp24 and its Trp mutants was studied using 
circular dichroism and fluorescence spectroscopy. The far-UV circular dichroism 
spectrum of the wild type protein is similar to that described for the capsid protein of 
HIV-1 [33,34] and EIAV [35], and indicates that FIV-rp24 is predominantly α-helical. 
The percentage of FIV-rp24 α-helix calculated from the CD spectrum is coincident 
with that of EIAV-p26  [15] and HIV-p24 [16] as deduced from their crystal structure. 
Thus, as expected from their position at the ends of the polypeptide chain, the 14 
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extra amino acids of the recombinant protein, including the histidine tag, seem not to 
alter the overall structure. However, the possibility that the extra amino acids have 
some local effect or modify somehow the protein stability cannot be excluded from 
these studies. Moreover, the substitution of one or two tryptophan residues by 
phenylalanine did not have any influence in the far-UV CD spectrum of the protein, 
indicating that the secondary structure remained unchanged after the mutation and 
also that the aromatic side chains do not contribute to the CD spectrum in this 
wavelength range as it has been reported for proteins with a low intensity CD 
spectrum [36]. 
The aromatic side chains of FIV-rp24 contribute to the near-UV CD spectrum 
with a complex combination of Cotton effects, all positive for Trp40, positive and 
negative for Trp126 and all negative for the seven Tyr residues. The inserted Phe 
residues could have a low contribution to the spectrum of the mutants but always 
below 260 nm [23].  The spectra of Trp and Tyr residues could be added to obtain a 
composite spectrum which, except for the 250-265 nm range, has a high 
resemblance with that of wild type FIV-rp24. The practical coincidence of both 
spectra above 265 nm indicates that substitution of any Trp causes only alterations at 
the point of mutation without modifying the environment of the other Trp. The 
non-coincidence between the experimental and calculated spectra in the 
aforementioned range could be due to the fact that at least the double mutation has 
caused some minor conformational changes around the neighbor Tyr residues which 
have led to spectral changes in this wavelength region. Since the composite spectra 
are obtained by adding to the double mutant spectrum the individual  Trp 
contributions, they could not coincide with that of the wild type protein in the 250-265 
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nm region. Another plausible explanation is that small variations of protein 
concentration would render significant changes between the spectra, because of  
the high relative contribution of peptide bonds to the ellipticity values in that spectral 
range.  
The emission fluorescence of tryptophan and tyrosine vary widely from one 
protein to another due to the existence of quenching and resonance energy transfer 
processes [37, 38]. In the case of FIV-rp24 Tyr fluorescence accounts for almost 
40% of the fluorescence intensity upon excitation at 275 nm. Taking into account that 
there are seven Tyr residues, the average contribution of each Tyr (6%) is lower than 
that of each Trp (30%). The emission spectrum of W40/126F mutant gives the 
authentic Tyr contribution. Resonance energy transfer to nearby Trp should be 
responsible for the lower Tyr contribution exhibited by both wild type and single 
mutant proteins. Modeling of FIV-p24 structure with that described for EIAV-p26 [15] 
or HIV-p24 [16] indicates that Tyr to Trp energy transfer is a feasible process. 
Specifically, the distance from Tyr81 and Tyr127 to Trp126 and from Tyr127 to Trp40 
is within that necessary for energy transfer to take place. Moreover, this fact would 
account for the lower Tyr contribution to the fluorescence spectrum of wild type and 
W40F proteins. On the other hand, the different fluorescence intensities of W40F and 
W126F mutants upon excitation at 295 nm pointed out a different degree of 
quenching of the indole ring by close side chains. As a result Trp126 contributes 
double than Trp40 to the fluorescence intensity of FIV-rp24. The emission spectra 
obtained upon excitation at 295 nm provide additional indications that the changes 
induced by the substitutions should be restricted to the point where the mutations 
take place. Thus, the position of the maximum, 321-322 nm, does not change when 
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Phe residues are inserted. Moreover, addition of W40F and W126F spectra provides 
a spectrum which is similar in shape to that of wild type protein and with a 95% of its 
fluorescence intensity (data not shown).  
The spectroscopic properties of FIV-rp24 and single and double mutants 
indicate that the mutational changes introduced in the protein do not affect the overall 
tertiary structure. However, a difference in thermal stability of mutant proteins has 
been observed, indicating that the W126F and W40/126F mutants are thermally less 
stable than the wild type FIV-rp24 and W40F mutant. If the three-dimensional 
structure of lentiviral core proteins is conserved, Trp126 would occupy the “a” 
position of one of the heptad repeats of G helix while Trp40 would be in the heptad 
“g” position of B helix [12]. The former would take part in helix-helix contacts that 
make the bundle, a position which is more hydrophobic than that occupied by the 
later. Thus, Trp126 would contribute more to the stabilization of the 
three-dimensional structure and hence the lower thermal stability of W126F and 
W40/126F mutants. Anyway, the four proteins seem to be stable enough to be 
considered as valuable tools for the study of the folding mechanism of the protein. 
The assigned bands can be used as specific structural probes to follow the kinetics 
and the formation of folding intermediates which should help us to understand how 
the FIV-rp24 protein assumes its native conformation. 
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Table 1. Amino acid composition of FIV-rp24 and W40F, W126F and W40/126F 
mutants. 
 
 
AMINO ACID 
 
THEORETICa FIV-rp24 W40F W126F 
 
W40/126FF 
 
ALA 
 
33 32 33 32 
 
32  
ARG 
 
11 11 11 11 
 
11  
ASX 
 
15 16 15 16 
 
16  
CYS 
 
4 4b N.D.c N.D.c 
 
N.D.c 
GLX 
 
35 35 35 35 
 
35  
GLY 
 
11 12 12 12 
 
12  
HIS 
 
8 9 9 9 
 
9  
ILE 
 
11 11 11 11 
 
11  
LEU 
 
24 24 24 24 
 
24  
LYS 
 
15 14 15 15 
 
14  
MET 
 
9 8 8 8 
 
8  
PHE 
 
7 7 8 8 
 
9  
PRO 
 
14 15 15 15 
 
15  
SER 
 
12 11 11 11 
 
11  
THR 
 
11 11 11 10 
 
10  
TRPd 
 
2 2 1 1 
 
0  
TYR 
 
7 7 7 7 
 
7  
VAL 
 
8 8 7 8 
 
8 
 
a The theoretic composition was determined from the amino acid sequence deduced 
from the cDNA sequence. 
b The number of cysteine residues was determined as carboxymethylcysteine in the 
protein reduced and carboxyamidomethylated. 
cN.D., not determined. 
dThe number of tryptophan residues was calculated by the method of Edelhoch [21]. 
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Table 2. Secondary structure of FIV-rp24 and tryptophan mutants calculated 
from the CD spectra. The data were calculated according to the CCA method [20]. 
 
 
PROTEIN 
 
α-helix(%) 
 
β-sheet (%) β turn (%) Aperiodic (%) 
 
FIV-rp24 
 
48 
 
0 20 32 
 
W40F 
 
52 
 
0 18 30 
 
W126F 
 
51 
 
0 20 29 
 
W40/126F 
 
49 
 
5 14 32 
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LEGENDS 
 
Fig. 1. Cloning strategy for FIV-rp24. (A) Nucleotide sequence of the primers used 
to amplify the p24 gene. The p24-NcoI (+) primer introduces an NcoI restriction site, 
while the p24-BglII (-) primer introduces a BglII restriction site. (B) Alignment of the 
original and cloned amino-terminal sequences of FIV-p24. (C) Alignment of the 
original and cloned carboxy-terminal sequences of FIV-p24. New restriction sites are 
underlined (NcoI- CCATGG; BglII- AGATCT) and ‘TAA’ is the termination codon (*) 
for the cloned gene. 
 
Fig. 2. SDS-PAGE of the purification steps of the FIV-rp24 protein. Lane 1, 
molecular mass markers; lane 2, M15 cells without induction; lane 3, M15 cells 
induced with 0.25 mM IPTG for 4 h; lane 4, soluble proteins loaded onto a 
Ni-NTA-Agarose column; lane 5, FIV-rp24 eluted with 10 mM Tris, 200 mM Imidazol, 
pH 8.0.  
 
Fig. 3. Absorption spectra of FIV-rp24  and tryptophan mutant proteins. 
FIV-rp24 (──); W40F (---); W126F (--) and W40/126F (). The protein concentration 
was 1 mg/ml in all cases. The buffer employed was 10 mM sodium phosphate, pH 
7.0. 
 
Fig. 4. Circular dichroism spectra of FIV-rp24  and tryptophan mutant proteins. 
 Far-UV (A) and near-UV (B) CD spectra of FIV-rp24 (──); W40F (---); W126F (--) 
and W40/126F (). The protein concentration was 0.1 mg/ml (far-UV) and 1 mg/ml 
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(near-UV). The buffer employed was 10 mM sodium phosphate, pH 7.0. These 
spectra are representative of those obtained for three different preparations. 
Fig. 5. Contribution of Trp40 (A) and Trp126 (B) residues to the near-UV CD 
spectrum of FIV-rp24. The contributions of each Trp was calculated by subtracting 
the spectrum of the corresponding single mutant from the FIV-rp24 spectrum  (──) 
or the spectrum of the double mutant from that of the other mutant (---).  
 
Fig. 6. Near-UV CD spectrum of FIV-rp24 obtained by adding the contributions 
of tryptophan and tyrosine residues. The experimental spectrum of FIV-rp24 (──) 
is compared with those obtained by adding the spectrum of double mutant and the 
spectra of Trp40 and Trp126. The later are obtained as indicated in Fig. 5 by 
subtracting from the spectrum of FIV-rp24 the spectrum of the corresponding mutant 
(---) or from the spectrum of the other mutant the spectrum of the double mutant (--). 
 
Fig. 7. Fluorescence emission spectra of FIV-rp24 (A) and W40F (B), W126F  
(C) and W40/126F (D) mutants. Emission spectra were obtained upon excitation at 
275 nm (──) and  295 nm (---). The spectra obtained upon excitation at 295 nm are 
normalized. The protein concentration was 0.05-0.1 mg/ml. The buffer employed was 
10 mM sodium phosphate, pH 7.0. The contribution of tyrosine residues to the 
emission spectra of the protein (--) is calculated as indicated in the Experimental 
Procedures section. The spectra shown are representative of those obtained for 
three different preparations. 
 
Fig. 8. Thermal denaturation curves of FIV-rp24 (A), W40F (B), W126F (C) and 
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W40/126F (D). The ellipticity at 208 nm was continuously monitored as the 
temperature was continuously increased at 30 C/h rate. The protein concentration 
was 0.1-0.2 mg/ml and the buffer used was 10 mM sodium phosphate, pH 7.0. The 
curves shown are representative of those obtained for three different preparations. 
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